Boston Scientific to Acquire Penumbra in $14.5 Billion Deal
Boston Scientific announces acquisition of Penumbra for $14.5B, expanding into blood clot removal and neurovascular treatments to address cardiovascular diseases.
/ 1 item
#PEN↓